Pharma Trend: Companies are Waiving Drug Patents in Developing Countries
Elementum
MAY 23, 2016
In 2015, the World Trade Organization extended a waiver that will exempt developing countries from drug patent obligations until 2033. Until then,countries under the program will be able to continue purchasing, manufacturing, and importing cheaper generic medicines without breaching the patent rules of the WTO.
Let's personalize your content